April 19: Pricing Debate Puts Medicare Drug Reimbursement In Play Again
The US Medicare program has yet to get a grip on spending for physician-administered speciality drugs. A congressional advisory panel is attempting to do so in a recommendation to trim reimbursement rates and encourage drug competition ahead of a transition to competitive bidding.
April 19: Pricing Debate Puts Medicare Drug Reimbursement In Play Again
The US Medicare program has yet to get a grip on spending for physician-administered speciality drugs. A congressional advisory panel is attempting to do so in a recommendation to trim reimbursement rates and encourage drug competition ahead of a transition to competitive bidding.